Annual CFI
N/A
31 December 2023
Summary:
Fennec Pharmaceuticals annual cash flow from investing activities is not available.FENC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 September 2024
Summary:
Fennec Pharmaceuticals quarterly cash flow from investing activities is not available.FENC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 September 2024
Summary:
Fennec Pharmaceuticals TTM cash flow from investing activities is not available.FENC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FENC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
FENC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Fennec Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $0.00(0.0%) | - | - |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $0.00(0.0%) | $24.00 K(0.0%) |
| Dec 2009 | $24.00 K(-260.0%) | $0.00(0.0%) | $24.00 K(0.0%) |
| Sept 2009 | - | $0.00(-100.0%) | $24.00 K(0.0%) |
| June 2009 | - | $24.00 K(>+9900.0%) | $24.00 K(-260.0%) |
| Dec 2008 | -$15.00 K | $0.00(0.0%) | -$15.00 K(-100.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2008 | - | $0.00(0.0%) | $5.04 M(-9431.5%) |
| June 2008 | - | $0.00(-100.0%) | -$54.00 K(-40.0%) |
| Mar 2008 | - | -$15.00 K(-100.3%) | -$90.00 K(+20.0%) |
| Dec 2007 | -$75.00 K(-106.4%) | $5.05 M(-199.2%) | -$75.00 K(-98.5%) |
| Sept 2007 | - | -$5.09 M(>+9900.0%) | -$5.13 M(>+9900.0%) |
| June 2007 | - | -$36.00 K(<-9900.0%) | -$36.00 K(-109.2%) |
| Mar 2007 | - | $0.00(0.0%) | $391.00 K(-66.6%) |
| Dec 2006 | $1.17 M(-193.2%) | $0.00(0.0%) | $1.17 M(-65.6%) |
| Sept 2006 | - | $0.00(-100.0%) | $3.40 M(-6638.1%) |
| June 2006 | - | $391.00 K(-49.8%) | -$52.00 K(-88.6%) |
| Mar 2006 | - | $779.00 K(-65.1%) | -$457.00 K(-63.6%) |
| Dec 2005 | -$1.25 M(-82.3%) | $2.23 M(-164.6%) | -$1.25 M(-64.0%) |
| Sept 2005 | - | -$3.45 M(>+9900.0%) | -$3.48 M(+3999.8%) |
| June 2005 | - | -$14.00 K(-26.3%) | -$85.00 K(-98.8%) |
| Mar 2005 | - | -$19.00 K(-63.5%) | -$7.08 M(-0.3%) |
| Sept 2004 | - | -$52.00 K(-99.3%) | -$7.10 M(+0.5%) |
| June 2004 | -$7.07 M(-238.3%) | -$7.01 M(>+9900.0%) | -$7.07 M(-2052.3%) |
| Mar 2004 | - | -$35.40 K(+532.1%) | $362.20 K(-47.8%) |
| Dec 2003 | - | -$5600.00(-70.8%) | $694.50 K(-86.5%) |
| Sept 2003 | - | -$19.20 K(-104.5%) | $5.14 M(+0.5%) |
| June 2003 | $5.11 M(-188.2%) | $422.40 K(+42.3%) | $5.11 M(-681.7%) |
| Mar 2003 | - | $296.90 K(-93.3%) | -$878.90 K(-30.5%) |
| Dec 2002 | - | $4.44 M(<-9900.0%) | -$1.26 M(-78.2%) |
| Sept 2002 | - | -$45.00 K(-99.2%) | -$5.80 M(-0.0%) |
| June 2002 | -$5.80 M(+1693.6%) | -$5.57 M(+6235.3%) | -$5.80 M(+2439.2%) |
| Mar 2002 | - | -$87.90 K(-7.6%) | -$228.30 K(+62.6%) |
| Dec 2001 | - | -$95.10 K(+109.9%) | -$140.40 K(+209.9%) |
| Sept 2001 | - | -$45.30 K | -$45.30 K |
| June 2001 | -$323.20 K(+900.6%) | - | - |
| June 2000 | -$32.30 K | - | - |
FAQ
- What is the all time high annual CFI for Fennec Pharmaceuticals?
- What is the all time high quarterly CFI for Fennec Pharmaceuticals?
- What is the all time high TTM CFI for Fennec Pharmaceuticals?
What is the all time high annual CFI for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual cash flow from investing activities is $5.11 M
What is the all time high quarterly CFI for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly cash flow from investing activities is $5.05 M
What is the all time high TTM CFI for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high TTM cash flow from investing activities is $5.14 M